Bone Marrow Transplant Side Effects: Patient Guide
Bone Marrow Transplant Side Effects: An Honest Patient Guide
What to expect before, during, and after a BMT — from short-term discomfort to long-term risks — explained clearly so you can prepare, not panic.
By the Apex Hospitals Medical Editorial Team · Published June 2025
A bone marrow transplant (BMT) — also called a haematopoietic stem cell transplant (HSCT) — can be a life-saving procedure for patients with blood cancers such as leukaemia, lymphoma, and multiple myeloma, as well as certain inherited blood disorders. But it is also one of the most intensive treatments in modern medicine, and patients and families deserve a clear, honest account of what the side effects actually look like.
This guide draws on established clinical knowledge to walk you through the most common and the most serious complications — when they typically appear, how long they last, and what your medical team will do to manage them. If you or a loved one is considering a BMT, the haemato-oncology specialists at Apex Hospitals can help you weigh the risks against the potential benefit for your specific diagnosis.
What Happens to the Body During a BMT?
Before the transplant itself, patients undergo a conditioning regimen — high-dose chemotherapy, sometimes combined with total body irradiation — designed to destroy diseased bone marrow and suppress the immune system so it does not reject the new stem cells. This conditioning phase is the starting point for many of the side effects that follow.
Once the new stem cells are infused, the body enters a vulnerable period called engraftment, during which the donated cells travel to the bone marrow and begin producing healthy blood cells. This typically takes 2–4 weeks, and it is during this window that the risk of infection, bleeding, and other complications is highest.
Side effects can be broadly grouped into short-term (acute) effects that appear within the first few weeks, and long-term (chronic) effects that may emerge months or even years after the transplant.
Short-Term Side Effects (First 100 Days)
1. Nausea, Vomiting, and Mouth Sores (Mucositis)
High-dose chemotherapy irritates the lining of the entire digestive tract. Mucositis — painful sores in the mouth and throat — is one of the most distressing early side effects, making eating and swallowing difficult. Anti-nausea medications, mouth rinses, and nutritional support (including IV nutrition when needed) are standard parts of BMT care.
2. Severe Infection Risk
During the engraftment period, white blood cell counts drop to near zero — a state called neutropenia. Even a minor bacterial, viral, or fungal infection can become life-threatening. Patients are typically kept in protective isolation, given prophylactic antibiotics and antifungals, and monitored with daily blood counts. Intensive care support is available at Apex Hospitals for patients who develop serious infections during this phase.
3. Bleeding and Anaemia
Low platelet counts (thrombocytopenia) increase the risk of spontaneous bleeding — from the gums, nose, or internally. Red blood cell counts also fall, causing fatigue and breathlessness. Platelet and red cell transfusions are given as needed until the new marrow begins producing its own cells.
4. Organ Toxicity from Conditioning
The high-dose chemotherapy used in conditioning can stress the liver, kidneys, lungs, and heart. Veno-occlusive disease (VOD) of the liver — a blockage of small liver veins — is a serious but manageable complication that occurs in a minority of patients. Kidney function is monitored closely, and the team adjusts medications to minimise organ strain.
5. Fatigue
Profound fatigue is almost universal in the early weeks. It results from anaemia, the body's immune response, medications, and the psychological weight of the experience. Rest, gentle activity as tolerated, and nutritional support all help. The physiotherapy and rehabilitation team at Apex Hospitals works with BMT patients to rebuild strength progressively.
Graft-versus-Host Disease (GvHD): The Unique Risk of Allogeneic BMT
In an allogeneic transplant (using a donor's stem cells), the donated immune cells may recognise the patient's own body as foreign and attack it. This is called graft-versus-host disease (GvHD), and it is one of the most significant complications specific to allogeneic BMT.
Acute GvHD typically appears within the first 100 days and most commonly affects the skin (rash), gut (diarrhoea, cramping), and liver (jaundice, elevated enzymes). Chronic GvHD can develop after day 100 and may affect almost any organ system — skin, eyes, mouth, lungs, joints, and more — sometimes resembling an autoimmune disease.
According to the National Heart, Lung, and Blood Institute (NHLBI), GvHD occurs in 30–70% of allogeneic transplant recipients depending on the degree of donor match and other factors. Immunosuppressive medications (such as cyclosporine, tacrolimus, and steroids) are used to prevent and treat GvHD, though they in turn increase infection risk — a careful balancing act managed by the transplant team.
Interestingly, a mild degree of graft-versus-host reaction can actually be beneficial: the same immune response that causes GvHD can also attack residual cancer cells, an effect known as the graft-versus-leukaemia (GvL) effect.
Long-Term and Late Side Effects
Patients who successfully engraft and leave hospital are not finished with their recovery. Long-term follow-up is essential because several complications can emerge months or years later.
Hormonal and Fertility Changes
High-dose conditioning chemotherapy and radiation can damage the ovaries or testes, leading to early menopause in women and reduced fertility or infertility in men. Hormone replacement therapy and fertility preservation discussions (ideally before the transplant) are important parts of the care plan. The endocrinology team at Apex Hospitals supports BMT survivors with hormonal monitoring and management.
Secondary Cancers
The chemotherapy and radiation used in conditioning slightly increase the long-term risk of developing a secondary cancer — most commonly skin cancers, thyroid cancer, or secondary leukaemia. Regular cancer screening is part of long-term BMT follow-up. The oncology department at Apex Hospitals provides structured survivorship care for transplant recipients.
Lung Complications
Pulmonary complications — including bronchiolitis obliterans (a form of chronic GvHD affecting the lungs) and interstitial pneumonia — can affect BMT survivors. Lung function tests are performed regularly, and the pulmonary medicine specialists at Apex Hospitals are involved in managing these conditions.
Kidney and Bone Health
Long-term use of immunosuppressants, particularly calcineurin inhibitors, can affect kidney function over time. Bone density loss (osteoporosis) is also common, driven by steroid use, hormonal changes, and reduced physical activity during recovery. Calcium, vitamin D, and regular DEXA scans are part of survivorship monitoring. The nephrology team at Apex Hospitals monitors renal health in transplant survivors.
Psychological Impact
Anxiety, depression, and post-traumatic stress are recognised complications of BMT. The isolation, physical suffering, uncertainty about outcomes, and the long road to recovery take a significant psychological toll on patients and their families. Psychological support and counselling are not optional extras — they are a core part of comprehensive BMT care. The psychiatry and mental health team at Apex Hospitals works alongside the transplant unit to support patients through this journey.
Factors That Influence Your Risk Profile
Not every BMT patient experiences every complication. Several factors influence the severity and likelihood of side effects:
Type of transplant: Autologous (using your own stem cells) carries a lower risk of GvHD than allogeneic (donor) transplants.
Donor match: A fully matched sibling donor carries lower GvHD risk than a matched unrelated donor or a haploidentical (half-matched) donor.
Patient age and overall health: Younger patients with fewer pre-existing conditions generally tolerate BMT better.
Conditioning intensity: Reduced-intensity conditioning (RIC) regimens cause fewer short-term side effects and are increasingly used in older patients.
Underlying disease: The nature and stage of the disease being treated affects both the transplant approach and the risk profile.
Your transplant team will discuss your individual risk profile in detail before you consent to the procedure. This conversation should include an honest discussion of both the risks of the transplant and the risks of not having it.
What Does Recovery Actually Look Like?
Recovery from a BMT is measured in phases, not days. Most patients spend 3–6 weeks in hospital after the transplant infusion. After discharge, they typically remain close to the hospital for several more weeks for daily or twice-weekly outpatient reviews.
The first 100 days post-transplant are considered the highest-risk period. After that, if engraftment is stable and GvHD is controlled, patients gradually return to normal activities — though full immune reconstitution can take 1–2 years. Many patients return to work and normal life within 6–12 months, though this varies widely.
Nutrition plays a critical role in recovery. The dietetics and nutrition specialists at Apex Hospitals work with BMT patients to maintain adequate caloric and protein intake throughout the transplant process, which directly supports immune recovery and wound healing.
Frequently Asked Questions
Is a bone marrow transplant painful?
The stem cell infusion itself is not painful — it is administered like a blood transfusion. However, the conditioning chemotherapy and its side effects (mucositis, nausea, fatigue) can cause significant discomfort. Pain management is an active part of BMT care.
How long does it take to recover from a bone marrow transplant?
Most patients spend 3–6 weeks in hospital, followed by several months of close outpatient follow-up. Full immune recovery takes 1–2 years. Many patients return to work within 6–12 months, though this depends on the type of transplant, any complications, and the individual's overall health.
Can GvHD be prevented?
GvHD cannot always be prevented, but its risk can be reduced through careful donor matching, T-cell depletion techniques, and prophylactic immunosuppressive medications. When it does occur, it is treated with steroids and other immunosuppressants.
Are the side effects of an autologous BMT different from an allogeneic BMT?
Yes. Autologous BMT (using your own stem cells) does not carry the risk of GvHD, since there is no foreign immune system involved. However, it still involves high-dose conditioning chemotherapy, so short-term side effects like mucositis, infection risk, and fatigue are similar. The long-term risk profile is generally lower with autologous transplants.
What is the mortality risk of a bone marrow transplant?
Transplant-related mortality (TRM) varies widely depending on the type of transplant, the patient's age and health, and the underlying disease. Modern transplant programmes have significantly reduced TRM over the past two decades through better infection prevention, improved GvHD management, and supportive care advances. Your transplant team will give you specific figures relevant to your situation.
Is a bone marrow transplant available in Jaipur?
Yes. Apex Hospitals in Jaipur offers haemato-oncology services including evaluation and management of blood cancers that may require BMT. The team can guide you through the assessment process and, where appropriate, coordinate transplant care.
References
Have Questions About BMT for You or a Loved One?
The haemato-oncology team at Apex Hospitals, Jaipur is here to help you understand your options and navigate the path ahead with clarity and compassion.